SXI — what changed in the latest 10-Q
A section-by-section comparison of SXI's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-06 vs the prior 10-Q · 2026-02-02
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +20 | −18 | ~43 | 27 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~5 | 2 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 0 |
| Other information | Text added/removed | 0 | −5 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Legal proceedings, Risk factors
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-06
On March 9, 2026, we completed the divestiture of Federal Industries to a third party for cash proceeds of $68.3 million. The divestiture supports continued portfolio simplification and enables us to focus on larger businesses and fast growth end market opportunities. Post the divestiture, the Hydra…
We incurred deal related expenses of $2.5 million in the third quarter of fiscal year 2026 and $3.6 million in the first nine months of fiscal year 2026. Deal related expenses primarily consist of costs related to due diligence, advisory, legal, integration, and valuation activities associated with …
We recorded a gain on the sale of Federal Industries business of $56.8 million in the third quarter of fiscal year 2026. The sale transaction and financial results of Federal Industries are classified as continuing operations in the consolidated financial statements.
Interest expense for the third quarter of fiscal year 2026 was $7.3 million, a decline of $1.0 million from the prior year quarter, due primarily to lower average debt balance, more favorable interest rates and a favorable interest rate swap.
Interest expense for the nine months ended March 31, 2026 was $24.2 million, an increase of $9.2 million from the prior year period due primarily to higher average debt balance as compared to the prior year period as debt was used to finance the second and third quarter fiscal 2025 acquisitions.
Text removed vs the prior filing · source: 10-Q · 2026-02-02
We expect to start seeing realization of these restructuring actions during the second half of fiscal year 2026.
We incurred acquisition related expenses of $0.6 million in the second quarter of fiscal year 2026 and $1.0 million in the first six months of fiscal year 2026. Acquisition related expenses typically consist of due diligence, advisory, legal, integration, and valuation expenses incurred in connectio…
Interest expense for the second quarter of fiscal year 2026 was $7.9 million, an increase of $2.3 million from the prior year quarter. Interest expense for the six months ended December 31, 2025 was $16.8 million, an increase of $10.3 million from the prior year period. Our effective interest rate f…
The Company's effective tax rate from continuing operations for the second quarter of fiscal year 2026 and for the six months ended December 31, 2025 was 24.1% and 24.3%, respectively, compared with 35.5% and 22.6% for the prior year quarter and prior year period, respectively.
The tax rate was impacted in the three and six months ended December 31, 2025 by the following items: (i) changes in the geographic mix of earnings; (ii) the recognition of a discrete tax benefit related to equity compensation; (iii) foreign withholding taxes; and (iv) federal tax credits related to…
Other information
Text removed vs the prior filing · source: 10-Q · 2026-02-02
Sales are to be made commencing on or after February 16, 2026, in tranches with specified limit prices.
Thomas E. Chorman November 6, 2025 Rule 10b5-1 Trading Plan 500 to be sold November 6, 2026 (3) Sales are to be made commencing February 4, 2026 in ten equal monthly tranches through November 6, 2026 N/A
The subject shares are held as follows: (a) 15,000 shares indirectly in an irrevocable trust for which Mr. Dunbar is a trustee.
The plan terminates on the earliest to occur of (i) close of trading on February 26, 2027, or (ii) the date that the aggregate number of shares sold pursuant to the plan reaches 15,000 shares. The plan also terminates promptly upon the death, dissolution, bankruptcy or insolvency of the Seller. The …
The plan terminates on close of trading on November 6, 2026, or promptly upon the death, dissolution, bankruptcy or insolvency of the Seller.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice